114 related articles for article (PubMed ID: 17290460)
1. Comparing LRRK2 Gly2385Arg carriers with noncarriers.
Tan EK; Fook-Chong S; Yi Z
Mov Disord; 2007 Apr; 22(5):749-50. PubMed ID: 17290460
[No Abstract] [Full Text] [Related]
2. Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease.
Tan EK; Lee J; Chen CP; Wong MC; Zhao Y
Neurobiol Aging; 2009 Mar; 30(3):501-2. PubMed ID: 17720280
[TBL] [Abstract][Full Text] [Related]
3. Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant.
Tan EK; Schapira AH
Eur J Neurol; 2008 Mar; 15(3):203-4. PubMed ID: 18290841
[No Abstract] [Full Text] [Related]
4. Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians.
Tan EK; Zhao Y; Tan L; Lim HQ; Lee J; Yuen Y; Pavanni R; Wong MC; Fook-Chong S; Liu JJ
Mov Disord; 2007 Sep; 22(12):1816-8. PubMed ID: 17659642
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the LRRK2 Gly2385Arg variant in Alzheimer's disease in Taiwan.
Chang TY; Kuo HC; Lu CS; Wu-Chou YH; Huang CC
Parkinsonism Relat Disord; 2010 Jan; 16(1):28-30. PubMed ID: 19640773
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan.
Miyake Y; Tsuboi Y; Koyanagi M; Fujimoto T; Shirasawa S; Kiyohara C; Tanaka K; Fukushima W; Sasaki S; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
J Neurol Sci; 2010 Oct; 297(1-2):15-8. PubMed ID: 20673920
[TBL] [Abstract][Full Text] [Related]
7. Essential tremor and the common LRRK2 G2385R variant.
Tan EK; Lee J; Lim HQ; Yuen Y; Zhao Y
Parkinsonism Relat Disord; 2008 Nov; 14(7):569-71. PubMed ID: 18316234
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 mutations in Basque patients with Parkinson's disease.
Zarranz JJ; Gómez-Esteban JC
Lancet Neurol; 2008 Oct; 7(10):866-7; author reply 867. PubMed ID: 18848304
[No Abstract] [Full Text] [Related]
9. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).
Ruiz-Martínez J; Gorostidi A; Ibañez B; Alzualde A; Otaegui D; Moreno F; López de Munain A; Bergareche A; Gómez-Esteban JC; Martí Massó JF
Mov Disord; 2010 Oct; 25(14):2340-5. PubMed ID: 20721916
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
[TBL] [Abstract][Full Text] [Related]
11. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H
Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413
[No Abstract] [Full Text] [Related]
12. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
Ishihara L; Warren L; Gibson R; Amouri R; Lesage S; Dürr A; Tazir M; Wszolek ZK; Uitti RJ; Nichols WC; Griffith A; Hattori N; Leppert D; Watts R; Zabetian CP; Foroud TM; Farrer MJ; Brice A; Middleton L; Hentati F
Arch Neurol; 2006 Sep; 63(9):1250-4. PubMed ID: 16966502
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.
Simón-Sánchez J; Martí-Massó JF; Sánchez-Mut JV; Paisán-Ruiz C; Martínez-Gil A; Ruiz-Martínez J; Sáenz A; Singleton AB; López de Munain A; Pérez-Tur J
Mov Disord; 2006 Nov; 21(11):1954-9. PubMed ID: 16991141
[TBL] [Abstract][Full Text] [Related]
14. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease.
Elbaz A
Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536
[No Abstract] [Full Text] [Related]
15. Clinical heterogeneity of the LRRK2 G2019S mutation.
Papapetropoulos S; Singer C; Ross OA; Toft M; Johnson JL; Farrer MJ; Mash DC
Arch Neurol; 2006 Sep; 63(9):1242-6. PubMed ID: 16966501
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan.
Lu CS; Chang HC; Weng YH; Chen RS; Bonifati V; Wu-Chou YH
Parkinsonism Relat Disord; 2008; 14(5):393-6. PubMed ID: 18450497
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
18. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
An XK; Peng R; Li T; Burgunder JM; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Zhang ZJ
Eur J Neurol; 2008 Mar; 15(3):301-5. PubMed ID: 18201193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
